Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Danone CFO says China's baby formula plan 'not a surprise'

Published 06/13/2019, 07:00 AM
Updated 06/13/2019, 07:05 AM
© Reuters.  Danone CFO says China's baby formula plan 'not a surprise'

By Dominique Vidalon

PARIS (Reuters) - China's plan to increase local production of baby formula products has not come as a surprise to global dairy maker Danone, which has plans to launch a new ultra-premium product in that market, said Danone's chief financial officer.

According to a document jointly released earlier this month by China's central planner and several ministries, China aims to increase local production of baby formula so that more than 60% of the market can be supplied domestically.

The move could be a blow to the baby milk businesses of Nestle, Danone and Reckitt Benckiser which have generally flourished in China's $25 billion baby formula market.

"What is happening is not a surprise. At the end of the day there will be a few local players and international players. We see the category growing 3-5% in China with middle-class affluence," Finance Chief Cecile Cabanis told the Deutsche Bank (DE:DBKGn) Access Global Consumer Conference in Paris.

Growth was driven by demand from "lower-tier cities and for ultra premium" categories, she added.

China is an important growth market for Danone, contributing about 30% of sales to Danone's Early Life Nutrition (ELN) business which makes infant formula and baby food products.

Cabanis reiterated on Thursday that Danone expects its ELN business in China to return to growth in the second half of the year, having suffered a slump in the first quarter partly due to lower birth rates.

She added that focusing on premium products would help the division, and also said Danone had an "innovation in the pipeline" in that area, but declined to give more details.

Her comments come as rival Nestle plans to launch a new line of baby formula under an existing brand in China this year, targeting smaller cities.

Cabanis also reiterated Danone was confident of delivering all its financial targets for 2019 and 2020.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.